Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002369:Castration; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004054:Diethylstilbestrol / Q000008:administration & dosage; D004341:Drug Evaluation; D004961:Estramustine / Q000008:administration & dosage / Q000627:therapeutic use*; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D011238:Prednimustine / Q000008:administration & dosage; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D013607:Tablets; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D009588:Nitrogen Mustard Compounds; D013607:Tablets; D004961:Estramustine; D014750:Vincristine; D004054:Diethylstilbestrol; D003520:Cyclophosphamide; D011238:Prednimustine; D002945:Cisplatin; D005472:Fluorouracil